Efficacy and safety of istradefylline in patients with Parkinson's disease: An open-label, prospective study
Latest Information Update: 19 Oct 2020
At a glance
- Drugs Istradefylline (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- 16 Sep 2020 Status changed from recruiting to completed.
- 16 Sep 2020 Primary endpoint (mean change from baseline to week 24 in the 14item Unified Dystonia Rating Scale (UDRS) total score) has been met.
- 16 Sep 2020 Results presented at the 24th International Congress of Parkinson's Disease and Movement Disorders